Judson Englert
Directeur Technique/Scientifique/R&D chez CYTEIR THERAPEUTICS, INC.
Postes actifs de Judson Englert
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CYTEIR THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/06/2020 | - |
Historique de carrière de Judson Englert
Anciens postes connus de Judson Englert
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Medimmune, Inc. | Directeur Technique/Scientifique/R&D | - | - |
Formation de Judson Englert
| University of Pittsburgh | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Cyteir Therapeutics, Inc.
 Cyteir Therapeutics, Inc. BiotechnologyHealth Technology Cyteir Therapeutics, Inc.is a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies. The company was founded by Kevin Mills and Timothy Romberger in June 2012 and is headquartered in Lexington, MA. | Health Technology |
| Medimmune, Inc. | Health Technology |
- Bourse
- Insiders
- Judson Englert
- Expérience
